Literature DB >> 17532698

Reduced Peak Inspiratory Effort through the Diskus((R)) and the Turbuhaler((R)) due to Mishandling is Common in Clinical Practice.

Andrea S Melani1, Letizia S Bracci, Marcello Rossi.   

Abstract

OBJECTIVES: A minimum peak inspiratory flow (PIF) through dry powder inhalers (DPIs) is required for effective drug delivery to the lungs. Some patients are unable to generate the minimally effective PIF through the DPI. However, little information is available about the 'real life' prevalence of reduced peak inspiratory effort through the Diskus((R)) and the Turbuhaler((R)) as a result of mishandling
METHODS: We investigated peak inhalation effort through the Diskus((R)) and the Turbuhaler((R)) by both direct observation and the In-Check Dial((R)), a portable PIF meter, in a large sample of patients consecutively referred to our laboratory who were familiar with these devices. Patients with reduced peak inspiratory effort repeated the PIF measurement after a session of instruction on the need for more forceful effort through the device.
RESULTS: We studied 644 patients (mean age 62 years, 42% female). Of these, 62% had chronic obstructive pulmonary disease and 35% had asthma. The mean baseline forced expiratory volume in 1 second was 53% of predicted. 502 patients were using the Diskus((R)) and 185 the Turbuhaler((R)). Overall, 106 patients (16.5%) showed weak inhalation by direct observation at baseline. Of 44 subjects with weak inhalation through the Turbuhaler((R)), 34 (77%) demonstrated a PIF <30 L/min. Post-counselling, only four patients did not achieve a PIF of at least 30 L/min (p < 0.01). Of 62 subjects with weak inhalation through the Diskus((R)), 37 (60%) had a PIF <30 L/min. Post-counselling, all these subjects achieved a PIF of at least 30 L/min (p < 0.001).
CONCLUSION: A significant number of patients show a reduced peak inspiratory effort through the Diskus((R)) and the Turbuhaler((R)) in real life. Our results indicate that the cause of this deficiency is often mishandling of the device because, after a brief session of instruction on the need for more forceful inhalation, most patients obtained an acceptable PIF rate. A PIF meter may identify patients with inadequately weak inhalation and offer useful feedback for obtaining the best inspiratory effort.

Entities:  

Year:  2005        PMID: 17532698     DOI: 10.2165/00044011-200525080-00007

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  25 in total

1.  Optical feedback training of inhalation with Autohaler and Turbuhaler in COPD patients.

Authors:  J Steier; T Trammer; R M Cloes; W Petro
Journal:  Lung       Date:  2003       Impact factor: 2.584

2.  Multiple inhalers confuse asthma patients.

Authors:  J van der Palen; J J Klein; C L van Herwaarden; G A Zielhuis; E R Seydel
Journal:  Eur Respir J       Date:  1999-11       Impact factor: 16.671

3.  Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).

Authors:  T Engel; J H Heinig; F Madsen; K Nikander
Journal:  Eur Respir J       Date:  1990-10       Impact factor: 16.671

4.  Problems patients have using pressurized aerosol inhalers.

Authors:  G K Crompton
Journal:  Eur J Respir Dis Suppl       Date:  1982

5.  Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.

Authors:  Israel Amirav; Michael T Newhouse; Yasser Mansour
Journal:  Pediatr Pulmonol       Date:  2005-05

6.  Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates.

Authors:  H Chrystyn
Journal:  Respir Med       Date:  2003-02       Impact factor: 3.415

7.  Peak inspiratory flow through Turbuhaler in chronic obstructive airways disease.

Authors:  M H Dewar; A Jamieson; A McLean; G K Crompton
Journal:  Respir Med       Date:  1999-05       Impact factor: 3.415

8.  Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI.

Authors:  J Lenney; J A Innes; G K Crompton
Journal:  Respir Med       Date:  2000-05       Impact factor: 3.415

9.  The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient.

Authors:  Wolfgang E S Kamin; Tilman Genz; Sascha Roeder; Gerhard Scheuch; Rolf Cloes; Ralf Juenemann; Thomas Trammer
Journal:  J Aerosol Med       Date:  2003

10.  In Check Dial: accuracy for Diskus and Turbuhaler.

Authors:  Marielle E A C Broeders; Johan Molema; Niek A Vermue; Hons Th M Folgering
Journal:  Int J Pharm       Date:  2003-02-18       Impact factor: 5.875

View more
  6 in total

1.  Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.

Authors:  Mathieu Molimard; Paul Colthorpe
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-09-29       Impact factor: 2.849

2.  A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old.

Authors:  Wolfgang Kamin; Marion Frank; Sabine Kattenbeck; Petra Moroni-Zentgraf; Herbert Wachtel; Stefan Zielen
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-04-06       Impact factor: 2.849

3.  The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.

Authors:  Sinthia Bosnic-Anticevich; Henry Chrystyn; Richard W Costello; Myrna B Dolovich; Monica J Fletcher; Federico Lavorini; Roberto Rodríguez-Roisin; Dermot Ryan; Simon Wan Yau Ming; David B Price
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-21

4.  Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases.

Authors:  Theerasuk Kawamatawong; Supattra Khiawwan; Prapaporn Pornsuriyasak
Journal:  J Asthma Allergy       Date:  2017-02-23

Review 5.  Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jill A Ohar; Gary T Ferguson; Donald A Mahler; M Bradley Drummond; Rajiv Dhand; Roy A Pleasants; Antonio Anzueto; David M G Halpin; David B Price; Gail S Drescher; Haley M Hoy; John Haughney; Michael W Hess; Omar S Usmani
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-06

Review 6.  Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.

Authors:  Barbara P Yawn; Gene L Colice; Rick Hodder
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.